Big Gain For Keros Therapeutics, Inc.
Keros Therapeutics, Inc. (KROS:NASDAQ) jumped higher at $62.21, a gain of 28.9%. On Mon 24 Aug 20, KROS:NASDAQ touched a New 2-Week High of $48.25. The stock got featured on our News Catalysts scanner on Thu 13 Aug 20 at 07:18 AM in the 'EARNINGS' category. From Mon 10 Aug 20, the stock recorded 70.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Keros Therapeutics, Inc. (KROS:NASDAQ)
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
Top 10 Gainers:
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 67.86%
- FTSI (FTSI:NYSEMKT), 38.41%
- BIGC (BIGC:NASDAQ), 36.87%
- Lonestar Resources US Inc. (LONE:NASDAQ), 34.81%
- Viveve Medical, Inc. (VIVE:NASDAQ), 33.96%
- Jiayin Group Inc. (JFIN:NASDAQ), 33.33%
- Keros Therapeutics, Inc. (KROS:NASDAQ), 28.93%
- Phoenix Tree Holdings Limited (DNK:NYSE), 28.35%
- MediWound Ltd. (MDWD:NASDAQ), 26.54%
- VivoPower International PLC (VVPR:NASDAQ), 25.23%